Innate immune receptors on neutrophils and their role in chronic lung disease

European Journal of Clinical Investigation

Volumn 39, Issue 7, 2009, Pages 535-547

  Koller, B ^a,b   Bals, R ^c   Roos, D ^d   Korting, H C ^a   Griese, M ^a   Hartl, D ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Chronic lung diseases; COPD; Cystic fibrosis; Lung; Neutrophils; Toll like receptors

Indexed keywords

CELL SURFACE RECEPTOR; CHEMOKINE RECEPTOR CXCR; CHEMOKINE RECEPTOR CXCR4; CIGARETTE SMOKE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; SCAVENGER RECEPTOR; STROMAL CELL DERIVED FACTOR 1; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ASTHMA; BACTERIAL INFECTION; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; EPITHELIUM CELL; FIBROSING ALVEOLITIS; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; IMMUNOREGULATION; INNATE IMMUNITY; LUNG FIBROSIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR GENE; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INFLAMMATION; REVIEW; VIRUS PNEUMONIA;

CHRONIC DISEASE; HUMANS; IMMUNITY, INNATE; LUNG DISEASES; NEUTROPHILS; RECEPTORS, IMMUNOLOGIC; TOLL-LIKE RECEPTORS;

EID: 66849099549     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02145.x     Document Type: Review

References (192)

1. Murray CJ, Lopez AD, Jamison DT. The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ 1994 72 : 495 509. (Pubitemid 24232515)
2. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997 349 : 1436 42.
3. GOLD. Global initiative for chronic obstructive lung disease. GOLD Initiative 2008 3 : 438 46.
4. Mannino DM, Kiriz VA. Changing the burden of COPD mortality. Int J Chron Obstruct Pulmon Dis 2006 1 : 219 33.
5. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007 370 : 765 73.
6. Davis PB, Drumm M, Konstan MW. Cystic fibrosis. Am J Respir Crit Care Med 1996 154 : 1229 56.
7. Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H et al. Inflammatory cytokines in cystic-fibrosis lungs. Am J Respir Crit Care Med 1995 152 : 2111 8.
8. Doring G, Albus A, Hoiby N. Immunologic aspects of cystic fibrosis. Chest 1988 94 : 109S 15S.
9. Doring G, Worlitzsch D. Inflammation in cystic fibrosis and its management. Paediatr Respir Rev 2000 1 : 101 6.
10. Saetta M, Baraldo S, Corbino L, Turato G, Braccioni F, Rea F et al. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999 160 : 711 7.
11. Buhl R, Meyer A, Vogelmeier C. Oxidant-protease interaction in the lung. Prospects for antioxidant therapy. Chest 1996 110 : 267S 72S.
12. Buhling F, Groneberg D, Welte T. Proteases and their role in chronic inflammatory lung diseases. Curr Drug Targets 2006 7 : 751 9.
13. Ogushi F, Hubbard RC, Vogelmeier C, Fells GA, Crystal RG. Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung alpha 1-antitrypsin for neutrophil elastase. J Clin Invest 1991 87 : 1060 5.
14. Vogelmeier C, Hubbard RC, Fells GA, Schnebli HP, Thompson RC, Fritz H et al. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor. J Clin Invest 1991 87 : 482 8.
15. Vogelmeier C, Gillissen A, Buhl R. Use of secretory leukoprotease inhibitor to augment lung antineutrophil elastase activity. Chest 1996 110 : 261S 6S.
16. Vogelmeier C, Koczulla R, Fehrenbach H, Bals R. Pathogenesis of chronic obstructive pulmonary disease. Internist (Berl) 2006 47 : 885 90.
17. Abraham E. Neutrophils and acute lung injury. Crit Care Med 2003 31 : S195 9.
18. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 2006 6 : 173 82.
19. Ricevuti G. Host tissue damage by phagocytes. Ann N Y Acad Sci 1997 832 : 426 48.
20. Roos D, Dolman KM. Neutrophil involvement in inflammatory tissue damage. Neth J Med 1990 36 : 89 94. (Pubitemid 20125963)
21. Roos D, Winterbourn CC. Immunology. Lethal weapons. Science 2002 296 : 669 71.
22. Ulevitch RJ. Recognition of bacterial endotoxins by receptor-dependent mechanisms. Adv Immunol 1993 53 : 267 89.
23. Zhang FX, Kirschning CJ, Mancinelli R, Xu XP, Jin Y, Faure E et al. Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J Biol Chem 1999 274 : 7611 4.
24. Mollinedo F, Borregaard N, Boxer LA. Novel trends in neutrophil structure, function and development. Immunol Today 1999 20 : 535 7.
25. Condliffe AM, Kitchen E, Chilvers ER. Neutrophil priming: pathophysiological consequences and underlying mechanisms. Clin Sci (Lond) 1998 94 : 461 71.
26. Guthrie LA, McPhail LC, Henson PM, Johnston RB Jr. Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme. J Exp Med 1984 160 : 1656 71.
27. DeLeo FR, Renee J, McCormick S, Nakamura M, Apicella M, Weiss JP et al. Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly. J Clin Invest 1998 101 : 455 63.
28. Lee A, Whyte MK, Haslett C. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol 1993 54 : 283 8.
29. Wagner JG, Roth RA. Neutrophil migration during endotoxemia. J Leukoc Biol 1999 66 : 10 24. (Pubitemid 29321365)
30. Vandivier RW, Henson PM, Douglas IS. Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest 2006 129 : 1673 82.
31. Martin C, Burdon PC, Bridger G, Gutierrez-Ramos JC, Williams TJ, Rankin SM. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity 2003 19 : 583 93.
32. MacNee W, Selby C. New perspectives on basic mechanisms in lung disease. 2. Neutrophil traffic in the lungs: role of haemodynamics, cell adhesion, and deformability. Thorax 1993 48 : 79 88.
33. Ramaiah SK, Jaeschke H. Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol Pathol 2007 35 : 757 66.
34. Swain SD, Rohn TT, Quinn MT. Neutrophil priming in host defense: role of oxidants as priming agents. Antioxid Redox Signal 2002 4 : 69 83. (Pubitemid 34260688)
35. Hartl D, Latzin P, Hordijk P, Marcos V, Rudolph C, Woischnik M et al. Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat Med 2007 13 : 1423 30.
36. Tirouvanziam R, Gernez Y, Conrad CK, Moss RB, Schrijver I, Dunn CE et al. Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways. Proc Natl Acad Sci USA 2008 105 : 4335 9.
37. Dallegri F, Ottonello L. Tissue injury in neutrophilic inflammation. Inflamm Res 1997 46 : 382 91.
38. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989 320 : 365 76.
39. Kinder BW, King TE Jr. Prognostic significance of bronchoalveolar lavage cellular analysis in scleroderma lung disease. Am J Respir Crit Care Med 2008 177 : 1292 3.
40. Kinder BW, Brown KK, Schwarz MI, Ix JH, Kervitsky A, King TE Jr. Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis. Chest 2008 133 : 226 32.
41. McNamara PS, Ritson P, Selby A, Hart CA, Smyth RL. Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. Arch Dis Child 2003 88 : 922 6.
42. Klockmann MT, Jahn HU, Hippenstiel S, Kramer HJ, Suttorp N. Interaction of human neutrophils with airway epithelial cells: reduction of leukotriene B4 generation by epithelial cell derived prostaglandin E2. J Cell Physiol 1998 175 : 268 75.
43. Wright JR. Host defense functions of pulmonary surfactant. Biol Neonate 2004 85 : 326 32.
44. Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 2005 5 : 58 68. (Pubitemid 40070331)
45. van Houwelingen AH, Weathington NM, Verweij V, Blalock JE, Nijkamp FP, Folkerts G. Induction of lung emphysema is prevented by L-arginine-threonine- arginine. FASEB J 2008 22 : 3403 8.
46. Gaggar A, Li Y, Weathington N, Winkler M, Kong M, Jackson P et al. Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients. Am J Physiol Lung Cell Mol Physiol 2007 293 : L96 104.
47. Weathington NM, van Houwelingen AH, Noerager BD, Jackson PL, Kraneveld AD, Galin FS et al. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat Med 2006 12 : 317 23.
48. Martin TR. Neutrophils and lung injury: getting it right. J Clin Invest 2002 110 : 1603 5.
49. Stockley RA. Neutrophils and the pathogenesis of COPD. Chest 2002 121 : 151S 5S.
50. Sprent J, Cho JH. Self/non-self discrimination and the problem of keeping T cells alive. Immunol Cell Biol 2008 86 : 54 6.
51. Sioud M. Innate sensing of self and non-self RNAs by Toll-like receptors. Trends Mol Med 2006 12 : 167 76.
52. Kreuwel HT, Sherman LA. The T-cell repertoire available for recognition of self-antigens. Curr Opin Immunol 2001 13 : 639 43.
53. Strominger JL. Developmental biology of T cell receptors. Science 1989 244 : 943 50.
54. Takeuchi O, Kawai T, Sanjo H, Copeland NG, Gilbert DJ, Jenkins NA et al. TLR6: A novel member of an expanding toll-like receptor family. Gene 1999 231 : 59 65. (Pubitemid 29307773)
55. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 1998 95 : 588 93.
56. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997 388 : 394 7.
57. Chuang TH, Ulevitch RJ. Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur Cytokine Netw 2000 11 : 372 8.
58. Areschoug T, Gordon S. Pattern recognition receptors and their role in innate immunity: focus on microbial protein ligands. Contrib Microbiol 2008 15 : 45 60.
59. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, Gordon S. Macrophage receptors and immune recognition. Annu Rev Immunol 2005 23 : 901 44.
60. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell 2002 111 : 927 30.
61. Takeda K, Akira S. Toll-like receptors. Curr Protoc Immunol 2007 Chapter 14:Unit 8 : 103 11.
62. Janssens S, Beyaert R. Role of Toll-like receptors in pathogen recognition. Clin Microbiol Rev 2003 16 : 637 46.
63. Netea MG, Van der Meer JW, Kullberg BJ. Recognition of pathogenic microorganisms by Toll-like receptors. Drugs Today (Barc) 2006 42 (Suppl. A 99 105.
64. Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 1999 285 : 736 9.
65. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999 274 : 17406 9.
66. Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000 68 : 6398 401.
67. Sebastiani G, Leveque G, Lariviere L, Laroche L, Skamene E, Gros P et al. Cloning and characterization of the murine toll-like receptor 5 (Tlr5) gene: sequence and mRNA expression studies in Salmonella-susceptible MOLF/Ei mice. Genomics 2000 64 : 230 40.
68. Zhang Z, Schluesener HJ. Mammalian toll-like receptors: from endogenous ligands to tissue regeneration. Cell Mol Life Sci 2006 63 : 2901 7.
69. Wagner H. Endogenous TLR ligands and autoimmunity. Adv Immunol 2006 91 : 159 73.
70. Takeuchi O, Hoshino K, Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 2000 165 : 5392 6.
71. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000 25 : 187 91.
72. Rhee SH, Hwang D. Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase. J Biol Chem 2000 275 : 34035 40.
73. Lehrer RI, Ganz T. Defensins of vertebrate animals. Curr Opin Immunol 2002 14 : 96 102. (Pubitemid 34085112)
74. Tzou P, Reichhart JM, Lemaitre B. Constitutive expression of a single antimicrobial peptide can restore wild-type resistance to infection in immunodeficient Drosophila mutants. Proc Natl Acad Sci USA 2002 99 : 2152 7.
75. Thoma-Uszynski S, Stenger S, Takeuchi O, Ochoa MT, Engele M, Sieling PA et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 2001 291 : 1544 7.
76. Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, Bassetti M et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999 401 : 811 5.
77. Thoma-Uszynski S, Kiertscher SM, Ochoa MT, Bouis DA, Norgard MV, Miyake K et al. Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J Immunol 2000 165 : 3804 10.
78. Visintin A, Mazzoni A, Spitzer JH, Wyllie DH, Dower SK, Segal DM. Regulation of Toll-like receptors in human monocytes and dendritic cells. J Immunol 2001 166 : 249 55.
79. Dziarski R. Peptidoglycan and lipopolysaccharide bind to the same binding site on lymphocytes. J Biol Chem 1991 266 : 4719 25.
80. Frantz S, Kobzik L, Kim YD, Fukazawa R, Medzhitov R, Lee RT et al. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest 1999 104 : 271 80.
81. Frantz S, Kelly RA, Bourcier T. Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes. J Biol Chem 2001 276 : 5197 203.
82. Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC, Podolsky DK. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol 2000 164 : 966 72.
83. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000 68 : 7010 7.
84. Hayashi F, Means TK, Luster AD. Toll-like receptors stimulate human neutrophil function. Blood 2003 102 : 2660 9.
85. Kurt-Jones EA, Mandell L, Whitney C, Padgett A, Gosselin K, Newburger PE et al. Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood 2002 100 : 1860 8.
86. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000 1 : 398 401.
87. Flo TH, Halaas O, Torp S, Ryan L, Lien E, Dybdahl B et al. Differential expression of Toll-like receptor 2 in human cells. J Leukoc Biol 2001 69 : 474 81.
88. Muzio M, Bosisio D, Polentarutti N, D'amico G, Stoppacciaro A, Mancinelli R et al. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 2000 164 : 5998 6004. (Pubitemid 30389848)
89. Roilides E, Uhlig K, Venzon D, Pizzo PA, Walsh TJ. Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect Immun 1993 61 : 1185 93.
90. Roilides E, Holmes A, Blake C, Pizzo PA, Walsh TJ. Effects of granulocyte colony-stimulating factor and interferon-gamma on antifungal activity of human polymorphonuclear neutrophils against pseudohyphae of different medically important Candida species. J Leukoc Biol 1995 57 : 651 6.
91. Wollin L, Uhlig S, Nusing R, Wendel A. Granulocyte-macrophage colony-stimulating factor amplifies lipopolysaccharide-induced bronchoconstriction by a neutrophil- and cyclooxygenase 2-dependent mechanism. Am J Respir Crit Care Med 2001 163 : 443 50.
92. Fossati G, Mazzucchelli I, Gritti D, Ricevuti G, Edwards SW, Moulding DA et al. In vitro effects of GM-CSF on mature peripheral blood neutrophils. Int J Mol Med 1998 1 : 943 51.
93. Alvarez ME, Fuxman Bass JI, Geffner JR, Calotti PX, Costas M, Coso OA et al. Neutrophil signaling pathways activated by bacterial DNA stimulation. J Immunol 2006 177 : 4037 46.
94. Jozsef L, Khreiss T, El Kebir D, Filep JG. Activation of TLR-9 induces IL-8 secretion through peroxynitrite signaling in human neutrophils. J Immunol 2006 176 : 1195 202.
95. Jozsef L, Khreiss T, Filep JG. CpG motifs in bacterial DNA delay apoptosis of neutrophil granulocytes. FASEB J 2004 18 : 1776 8.
96. Sabroe I, Prince LR, Jones EC, Horsburgh MJ, Foster SJ, Vogel SN et al. Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span. J Immunol 2003 170 : 5268 75.
97. Sabroe I, Dower SK, Whyte MK. The role of Toll-like receptors in the regulation of neutrophil migration, activation, and apoptosis. Clin Infect Dis 2005 41 (Suppl. 7 S421 6.
98. Sabroe I, Whyte MK. Toll-like receptor (TLR)-based networks regulate neutrophilic inflammation in respiratory disease. Biochem Soc Trans 2007 35 : 1492 5.
99. Hartl D, Griese M, Kappler M, Zissel G, Reinhardt D, Rebhan C et al. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. J Allergy Clin Immunol 2006 117 : 204 11.
100. Zhang P, Summer WR, Bagby GJ, Nelson S. Innate immunity and pulmonary host defense. Immunol Rev 2000 173 : 39 51. (Pubitemid 30095209)
101. Konstan MW, Berger M. Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatr Pulmonol 1997 24 : 137 42.
102. Murphy TF, Brauer AL, Eschberger K, Lobbins P, Grove L, Cai X et al. Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008 177 : 853 60.
103. Konstan MW, Hilliard KA, Norvell TM, Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 1994 150 : 448 54.
104. Davis PB, Drumm M, Konstan MW. Cystic fibrosis. Am J Respir Crit Care Med 1996 154 : 1229 56.
105. Berger M. Inflammatory mediators in cystic fibrosis lung disease. Allergy Asthma Proc 2002 23 : 19 25.
106. Wine JJ. The genesis of cystic fibrosis lung disease. J Clin Invest 1999 103 : 309 12.
107. Adamo R, Sokol S, Soong G, Gomez MI, Prince A. Pseudomonas aeruginosa flagella activate airway epithelial cells through asialoGM1 and toll-like receptor 2 as well as toll-like receptor 5. Am J Respir Cell Mol Biol 2004 30 : 627 34.
108. Zhang Z, Louboutin JP, Weiner DJ, Goldberg JB, Wilson JM. Human airway epithelial cells sense Pseudomonas aeruginosa infection via recognition of flagellin by Toll-like receptor 5. Infect Immun 2005 73 : 7151 60.
109. Hybiske K, Ichikawa JK, Huang V, Lory SJ, Machen TE. Cystic fibrosis airway epithelial cell polarity and bacterial flagellin determine host response to Pseudomonas aeruginosa. Cell Microbiol 2004 6 : 49 63. (Pubitemid 38111588)
110. Skerrett SJ, Wilson CB, Liggitt HD, Hajjar AM. Redundant Toll-Like Receptor Signaling in the Pulmonary Host Response to Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol 2006 292 : 312 22.
111. Balloy V, Verma A, Kuravi S, Si-Tahar M, Chignard M, Ramphal R. The role of flagellin versus motility in acute lung disease caused by Pseudomonas aeruginosa. J Infect Dis 2007 196 : 289 96.
112. Koller B, Kappler M, Latzin P, Gaggar A, Schreiner M, Takyar S et al. TLR expression on neutrophils at the pulmonary site of infection: TLR1/TLR2-mediated up-regulation of TLR5 expression in cystic fibrosis lung disease. J Immunol 2008 181 : 2753 63.
113. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004 4 : 499 511. (Pubitemid 38931765)
114. Yamamoto M, Takeda K, Akira S. TIR domain-containing adaptors define the specificity of TLR signaling. Mol Immunol 2004 40 : 861 8.
115. Petit-Bertron AF, Tabary O, Corvol H, Jacquot J, Clement A, Cavaillon JM et al. Circulating and airway neutrophils in cystic fibrosis display different TLR expression and responsiveness to interleukin-10. Cytokine 2008 41 : 54 60.
116. Elborn JS, Cordon SM, Western PJ, Macdonald IA, Shale DJ. Tumour necrosis factor-alpha, resting energy expenditure and cachexia in cystic fibrosis. Clin Sci (Lond) 1993 85 : 563 8.
117. Suter S, Schaad UB, Roux-Lombard P, Girardin E, Grau G, Dayer JM. Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis. Am Rev Respir Dis 1989 140 : 1640 4.
118. Norman D, Elborn JS, Cordon SM, Rayner RJ, Wiseman MS, Hiller EJ et al. Plasma tumour necrosis factor alpha in cystic fibrosis. Thorax 1991 46 : 91 5.
119. Shmarina GV, Pukhalsky AL, Kokarovtseva SN, Pukhalskaya DA, Shabalova LA, Kapranov NI et al. Tumor necrosis factor-alpha/interleukin-10 balance in normal and cystic fibrosis children. Mediators Inflamm 2001 10 : 191 7.
120. Armstrong DS, Grimwood K, Carlin JB, Carzino R, Gutierrez JP, Hull J et al. Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 1997 156 : 1197 204.
121. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DWH. Early pulmonary inflammation in infants with cystic-fibrosis. Am J Respir Crit Care Med 1995 151 : 1075 82.
122. Hawn TR, Verbon A, Lettinga KD, Zhao LP, Li SS, Laws RJ et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J Exp Med 2003 198 : 1563 72.
123. Domagala-Kulawik J. Effects of cigarette smoke on the lung and systemic immunity. J Physiol Pharmacol 2008 59 (Suppl. 6 19 34.
124. Pace E, Ferraro M, Siena L, Melis M, Montalbano AM, Johnson M et al. Cigarette smoke increases Toll-like receptor 4 and modifies lipopolysaccharide- mediated responses in airway epithelial cells. Immunology 2008 124 : 401 11.
125. Karimi K, Sarir H, Mortaz E, Smit JJ, Hosseini H, De Kimpe SJ et al. Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages. Respir Res 2006 7 : 66.
126. Laan M, Bozinovski S, Anderson GP. Cigarette smoke inhibits lipopolysaccharide-induced production of inflammatory cytokines by suppressing the activation of activator protein-1 in bronchial epithelial cells. J Immunol 2004 173 : 4164 70.
127. Gaschler GJ, Zavitz CC, Bauer CM, Skrtic M, Lindahl M, Robbins CS et al. Cigarette smoke exposure attenuates cytokine production by mouse alveolar macrophages. Am J Respir Cell Mol Biol 2008 38 : 218 26.
128. Kroening PR, Barnes TW, Pease L, Limper A, Kita H, Vassallo R. Cigarette smoke-induced oxidative stress suppresses generation of dendritic cell IL-12 and IL-23 through ERK-dependent pathways. J Immunol 2008 181 : 1536 47.
129. Mortaz E, Kraneveld AD, Smit JJ, Kool M, Lambrecht BN, Kunkel SL et al. Effect of cigarette smoke extract on dendritic cells and their impact on T-cell proliferation. PLoS ONE 2009 4 : e4946.
130. Robbins CS, Franco F, Mouded M, Cernadas M, Shapiro SD. Cigarette smoke exposure impairs dendritic cell maturation and T cell proliferation in thoracic lymph nodes of mice. J Immunol 2008 180 : 6623 8.
131. Kang MJ, Lee CG, Lee JY, Dela Cruz CS, Chen ZJ, Enelow R et al. Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice. J Clin Invest 2008 118 : 2771 84.
132. Gualano RC, Hansen MJ, Vlahos R, Jones JE, Park-Jones RA, Deliyannis G et al. Cigarette smoke worsens lung inflammation and impairs resolution of influenza infection in mice. Respir Res 2008 9 : 53.
133. Droemann D, Goldmann T, Tiedje T, Zabel P, Dalhoff K, Schaaf B. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir Res 2005 6 : 68.
134. Noakes PS, Hale J, Thomas R, Lane C, Devadason SG, Prescott SL. Maternal smoking is associated with impaired neonatal toll-like-receptor-mediated immune responses. Eur Respir J 2006 28 : 721 9.
135. Noakes PS, Thomas R, Lane C, Mori TA, Barden AE, Devadason SG et al. Association of maternal smoking with increased infant oxidative stress at 3 months of age. Thorax 2007 62 : 714 7.
136. Prescott SL. Effects of early cigarette smoke exposure on early immune development and respiratory disease. Paediatr Respir Rev 2008 9 : 3 9.
137. Bals R, Hiemstra PS. Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur Respir J 2004 23 : 327 33.
138. Hiemstra PS, Bals R. Series introduction: innate host defense of the respiratory epithelium. J Leukoc Biol 2004 75 : 3 4. (Pubitemid 38166773)
139. Shaykhiev R, Bals R. Interactions between epithelial cells and leukocytes in immunity and tissue homeostasis. J Leukoc Biol 2007 82 : 1 15. (Pubitemid 47026412)
140. Sadikot RT, Han W, Everhart MB, Zoia O, Peebles RS, Jansen ED et al. Selective I kappa B kinase expression in airway epithelium generates neutrophilic lung inflammation. J Immunol 2003 170 : 1091 8.
141. Mayer AK, Muehmer M, Mages J, Gueinzius K, Hess C, Heeg K et al. Differential recognition of TLR-dependent microbial ligands in human bronchial epithelial cells. J Immunol 2007 178 : 3134 42.
142. Ishii H, Fujii T, Hogg JC, Hayashi S, Mukae H, Vincent R et al. Contribution of IL-1 beta and TNF-alpha to the initiation of the peripheral lung response to atmospheric particulates (PM10). Am J Physiol Lung Cell Mol Physiol 2004 287 : L176 83.
143. Tsutsumi-Ishii Y, Nagaoka I. NF-kappa B-mediated transcriptional regulation of human beta-defensin-2 gene following lipopolysaccharide stimulation. J Leukoc Biol 2002 71 : 154 62.
144. Tsutsumi-Ishii Y, Nagaoka I. Modulation of human beta-defensin-2 transcription in pulmonary epithelial cells by lipopolysaccharide-stimulated mononuclear phagocytes via proinflammatory cytokine production. J Immunol 2003 170 : 4226 36.
145. Lentsch AB, Czermak BJ, Bless NM, Van Rooijen N, Ward PA. Essential role of alveolar macrophages in intrapulmonary activation of NF-kappaB. Am J Respir Cell Mol Biol 1999 20 : 692 8.
146. Noulin N, Quesniaux VF, Schnyder-Candrian S, Schnyder B, Maillet I, Robert T et al. Both hemopoietic and resident cells are required for MyD88-dependent pulmonary inflammatory response to inhaled endotoxin. J Immunol 2005 175 : 6861 9.
147. Hajjar AM, Harowicz H, Liggitt HD, Fink PJ, Wilson CB, Skerrett SJ. An essential role for non-bone marrow-derived cells in control of Pseudomonas aeruginosa pneumonia. Am J Respir Cell Mol Biol 2005 33 : 470 5.
148. Skerrett SJ, Liggitt HD, Hajjar AM, Wilson CB. Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus. J Immunol 2004 172 : 3377 81.
149. Skerrett SJ, Liggitt HD, Hajjar AM, Ernst RK, Miller SI, Wilson CB. Respiratory epithelial cells regulate lung inflammation in response to inhaled endotoxin. Am J Physiol Lung Cell Mol Physiol 2004 287 : L143 52.
150. Shaykhiev R, Behr J, Bals R. Microbial patterns signaling via Toll-like receptors 2 and 5 contribute to epithelial repair, growth and survival. PLoS ONE 2008 3 : e1393.
151. Weindl G, Naglik JR, Kaesler S, Biedermann T, Hube B, Korting HC et al. Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling. J Clin Invest 2007 117 : 3664 72.
152. Wurfel MM, Gordon AC, Holden TD, Radella F, Strout J, Kajikawa O et al. Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am J Respir Crit Care Med 2008 178 : 710 20.
153. Kesh S, Mensah NY, Peterlongo P, Jaffe D, Hsu K, Van Den BM et al. TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation. Ann N Y Acad Sci 2005 1062 : 95 103.
154. Kormann MS, Depner M, Hartl D, Klopp N, Illig T, Adamski J et al. Toll-like receptor heterodimer variants protect from childhood asthma. J Allergy Clin Immunol 2008 122 : 86 92.
155. Buckland KF, O'Connor E, Murray LA, Hogaboam CM. Toll like receptor-2 modulates both innate and adaptive immune responses during chronic fungal asthma in mice. Inflamm Res 2008 57 : 379 87.
156. Da Silva CA, Hartl D, Liu W, Lee CG, Elias JA. TLR-2 and IL-17A in chitin-induced macrophage activation and acute inflammation. J Immunol 2008 181 : 4279 86.
157. Fuse ET, Tateda K, Kikuchi Y, Matsumoto T, Gondaira F, Azuma A et al. Role of Toll-like receptor 2 in recognition of Legionella pneumophila in a murine pneumonia model. J Med Microbiol 2007 56 : 305 12.
158. Saito T, Yamamoto T, Kazawa T, Gejyo H, Naito M. Expression of toll-like receptor 2 and 4 in lipopolysaccharide-induced lung injury in mouse. Cell Tissue Res 2005 321 : 75 88. (Pubitemid 40984841)
159. Lorenz E, Chemotti DC, Jiang AL, McDougal LD. Differential involvement of toll-like receptors 2 and 4 in the host response to acute respiratory infections with wild-type and mutant Haemophilus influenzae strains. Infect Immun 2005 73 : 2075 82.
160. Velasco G, Campo M, Manrique OJ, Bellou A, He H, Arestides RS et al. Toll-like receptor 4 or 2 agonists decrease allergic inflammation. Am J Respir Cell Mol Biol 2005 32 : 218 24.
161. Knapp S, Wieland CW, van' V, Takeuchi O, Akira S, Florquin S et al. Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense. J Immunol 2004 172 : 3132 8.
162. Joshi AD, Schaller MA, Lukacs NW, Kunkel SL, Hogaboam CM. TLR3 modulates immunopathology during a Schistosoma mansoni egg-driven Th2 response in the lung. Eur J Immunol 2008 38 : 3436 49.
163. Murray LA, Knight DA, McAlonan L, Argentieri R, Joshi A, Shaheen F et al. Deleterious role of TLR3 during hyperoxia-induced acute lung injury. Am J Respir Crit Care Med 2008 178 : 1227 37.
164. Rudd BD, Smit JJ, Flavell RA, Alexopoulou L, Schaller MA, Gruber A et al. Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection. J Immunol 2006 176 : 1937 42.
165. Guillot L, Le Goffic R, Bloch S, Escriou N, Akira S, Chignard M et al. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J Biol Chem 2005 280 : 5571 80.
166. Lembo A, Pelletier M, Iyer R, Timko M, Dudda JC, West TE et al. Administration of a synthetic TLR4 agonist protects mice from pneumonic tularemia. J Immunol 2008 180 : 7574 81.
167. Smith LS, Kajikawa O, Elson G, Wick M, Mongovin S, Kosco-Vilbois M et al. Effect of Toll-like receptor 4 blockade on pulmonary inflammation caused by mechanical ventilation and bacterial endotoxin. Exp Lung Res 2008 34 : 225 43.
168. Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, van Loo G et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 2008 133 : 235 49.
169. Ogawa Y, Tasaka S, Yamada W, Saito F, Hasegawa N, Miyasho T et al. Role of Toll-like receptor 4 in hyperoxia-induced lung inflammation in mice. Inflamm Res 2007 56 : 334 8.
170. Shimamoto A, Pohlman TH, Shomura S, Tarukawa T, Takao M, Shimpo H. Toll-like receptor 4 mediates lung ischemia-reperfusion injury. Ann Thorac Surg 2006 82 : 2017 23.
171. Zhang X, Shan P, Jiang G, Cohn L, Lee PJ. Toll-like receptor 4 deficiency causes pulmonary emphysema. J Clin Invest 2006 116 : 3050 9.
172. Maes T, Bracke KR, Vermaelen KY, Demedts IK, Joos GF, Pauwels RA et al. Murine TLR4 is implicated in cigarette smoke-induced pulmonary inflammation. Int Arch Allergy Immunol 2006 141 : 354 68.
173. Togbe D, Schnyder-Candrian S, Schnyder B, Couillin I, Maillet I, Bihl F et al. TLR4 gene dosage contributes to endotoxin-induced acute respiratory inflammation. J Leukoc Biol 2006 80 : 451 7.
174. Hollingsworth JW, Whitehead GS, Lin KL, Nakano H, Gunn MD, Schwartz DA et al. TLR4 signaling attenuates ongoing allergic inflammation. J Immunol 2006 176 : 5856 62.
175. Janardhan KS, McIsaac M, Fowlie J, Shrivastav A, Caldwell S, Sharma RK et al. Toll like receptor-4 expression in lipopolysaccharide induced lung inflammation. Histol Histopathol 2006 21 : 687 96.
176. Alves-Filho JC, de Freitas A, Russo M, Cunha FQ. Toll-like receptor 4 signaling leads to neutrophil migration impairment in polymicrobial sepsis. Crit Care Med 2006 34 : 461 70.
177. Zhang X, Shan P, Qureshi S, Homer R, Medzhitov R, Noble PW et al. Cutting edge: TLR4 deficiency confers susceptibility to lethal oxidant lung injury. J Immunol 2005 175 : 4834 8.
178. Lee JS, Frevert CW, Matute-Bello G, Wurfel MM, Wong VA, Lin SM et al. TLR-4 pathway mediates the inflammatory response but not bacterial elimination in E. coli pneumonia. Am J Physiol Lung Cell Mol Physiol 2005 289 : L731 8.
179. Branger J, Leemans JC, Florquin S, Weijer S, Speelman P, van der PT. Toll-like receptor 4 plays a protective role in pulmonary tuberculosis in mice. Int Immunol 2004 16 : 509 16.
180. Shim TS, Turner OC, Orme IM. Toll-like receptor 4 plays no role in
181. Andonegui G, Bonder CS, Green F, Mullaly SC, Zbytnuik L, Raharjo E et al. Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs. J Clin Invest 2003 111 : 1011 20.
182. Abel B, Thieblemont N, Quesniaux VJ, Brown N, Mpagi J, Miyake K et al. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol 2002 169 : 3155 62.
183. Schwartz DA. TLR4 and LPS hyporesponsiveness in humans. Int J Hyg Environ Health 2002 205 : 221 7.
184. Blohmke CJ, Victor RE, Hirschfeld AF, Elias IM, Hancock DG, Lane CR et al. Innate immunity mediated by TLR5 as a novel antiinflammatory target for cystic fibrosis lung disease. J Immunol 2008 180 : 7764 73.
185. Hawn TR, Berrington WR, Smith IA, Uematsu S, Akira S, Aderem A et al. Altered inflammatory responses in TLR5-deficient mice infected with Legionella pneumophila. J Immunol 2007 179 : 6981 7.
186. Sugawara I, Yamada H, Li C, Mizuno S, Takeuchi O, Akira S. Mycobacterial infection in TLR2 and TLR6 knockout mice. Microbiol Immunol 2003 47 : 327 36.
187. Pawar RD, Ramanjaneyulu A, Kulkarni OP, Lech M, Segerer S, Anders HJ. Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus. J Am Soc Nephrol 2007 18 : 1721 31.
188. Camateros P, Tamaoka M, Hassan M, Marino R, Moisan J, Marion D et al. Chronic asthma-induced airway remodeling is prevented by toll-like receptor-7/8 ligand S28463. Am J Respir Crit Care Med 2007 175 : 1241 9.
189. Hammerbeck DM, Burleson GR, Schuller CJ, Vasilakos JP, Tomai M, Egging E et al. Administration of a dual toll-like receptor 7 and toll-like receptor 8 agonist protects against influenza in rats. Antiviral Res 2007 73 : 1 11. (Pubitemid 46080481)
190. Ito T, Schaller M, Hogaboam CM, Standiford TJ, Sandor M, Lukacs NW et al. TLR9 regulates the mycobacteria-elicited pulmonary granulomatous immune response in mice through DC-derived Notch ligand delta-like 4. J Clin Invest 2009 119 : 33 46.
191. Bhan U, Trujillo G, Lyn-Kew K, Newstead MW, Zeng X, Hogaboam CM et al. Toll-like receptor 9 regulates the lung macrophage phenotype and host immunity in murine pneumonia caused by Legionella pneumophila. Infect Immun 2008 76 : 2895 904.
192. Knuefermann P, Baumgarten G, Koch A, Schwederski M, Velten M, Ehrentraut H et al. CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo. Respir Res 2007 8 : 72.